Breaking: FDA approves, authorizes updated monovalent COVID-19 vaccines
Bivalent COVID-19 vaccines by both Moderna and Pfizer-BioNTech are no longer authorized for use in the United States.
FDA explores new opioid disposal strategy
The agency is considering dispensing mail-back envelopes with outpatient opioid analgesic prescriptions.
Nonopioid analgesic, nonpharmacologic options for pain management reviewed
Combining nonopioid analgesics and nonpharmacologic pain management options with opioid medications can lead to better patient outcomes.
This Week in COVID-19: As new Omicron variant circulates, states lift mask mandates
COVID-19 updates and news to know as of February 21, 2022.
Novavax pediatric COVID-19 vaccine trial yields positive results
The NVX-CoV2373 vaccine was evaluated in adolescents aged 12 to 17 years.
This week in COVID-19: A patent-free COVID-19 vaccine may be on the horizon
COVID-19 updates and news to know as of January 17, 2022.
This week in COVID-19: Omicron spike leads to record case count
COVID-19 updates and news to know as of January 3, 2022.
Year in Review: 2021 top women’s health news from Drug Topics®
Take a look back at the top 10 women’s health news articles published on Drug Topics® this year.
Pharmacist prescribed contraceptive access program successful
Patients in California were able to receive a contraceptive prescription during a visit with a pharmacist.
This week in COVID-19: travel ban updates, Omicron uncertainty, and new vaccine mandates
COVID-19 updates and news to know as of December 6, 2021.
Breaking: In Unanimous Vote, ACIP Recommends Pfizer-BioNTech COVID-19 Vaccine for Children Ages 5 to 11
The next step in the approval process is the formal acceptance of the recommendation by CDC Director Rochelle P. Walensky, MD, MPH.
2 Clarke Drive Cranbury, NJ 08512